B Cells in Patients With Melanoma: Implications for Treatment With Checkpoint Inhibitor Antibodies

The contributions of the humoral immune response to melanoma are now widely recognized, with reports of positive prognostic value ascribed to tumor-infiltrating B cells (TIL-B) and increasing evidence of B cells as key predictors of patient response to treatment. There are disparate views as to the...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Immunol
Hlavní autoři: Willsmore, Zena N., Harris, Robert J., Crescioli, Silvia, Hussein, Khuluud, Kakkassery, Helen, Thapa, Deepika, Cheung, Anthony, Chauhan, Jitesh, Bax, Heather J., Chenoweth, Alicia, Laddach, Roman, Osborn, Gabriel, McCraw, Alexa, Hoffmann, Ricarda M., Nakamura, Mano, Geh, Jenny L., MacKenzie-Ross, Alastair, Healy, Ciaran, Tsoka, Sophia, Spicer, James F., Papa, Sophie, Barber, Linda, Lacy, Katie E., Karagiannis, Sophia N.
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2021
Témata:
Immunology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7868381/
https://ncbi.nlm.nih.gov/pubmed/33569063
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.622442
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky